Fondazione Italiana Linfomi - Ets

This study looked at how the drug mogamulizumab performed for patients with cutaneous T-cell lymphoma (CTCL) in everyday medical practice, not just in a controlled trial. It involved 100 adults in Italy who had already tried at least one other treatment. The goal was to confirm t…

This study tested whether adding a newer drug called venetoclax to standard chemotherapy could better control a difficult form of blood cancer called mantle cell lymphoma in older, high-risk patients. It involved 141 patients aged 65 and older who had not received prior treatment…

This study looked back at the medical records of 633 adults with a rare chest lymphoma (PMBCL) treated between 2007 and 2019. Researchers analyzed which standard chemotherapy treatments patients received and how well they worked in real-world hospital settings, outside of strict …

This study aimed to better understand the risk of heart damage in patients receiving a common chemotherapy regimen (R-CHOP) for a type of blood cancer called diffuse large B-cell lymphoma. Researchers observed 127 adult patients to identify early signs of heart problems linked to…

This study aimed to see if blood and urine tests could be as good as bone marrow biopsies for diagnosing and monitoring a rare blood cancer called Waldenström's macroglobulinemia. Researchers compared test results from 300 patients to find less invasive ways to track the disease.…

This study looked back at PET scan images from 200 patients with mantle cell lymphoma who were already part of a larger treatment trial. The goal was to see if information from these scans, taken at diagnosis and during treatment, could help doctors better predict how the disease…